TCI Wealth Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

TCI Wealth Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,265	Closed	-$176K	–	1486
2017 Q4	$176K	Hold	3,265	–	–	0.08%	169
2017 Q3	$186K	Hold	3,265	–	–	0.09%	149
2017 Q2	$196K	Buy	3,265 +41	+1%	+$2.33K	0.1%	137
2017 Q1	$176K	Buy	+3,224	New	+$159K	0.09%	146

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

TCI Wealth Advisors's BIVV Position: Q1 2018 in Review

TCI Wealth Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 3,265 shares — an estimated $176K sold.

TCI Wealth Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $196K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

TCI Wealth Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
TCI Wealth Advisors sold 3,265 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $176K.
TCI Wealth Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
TCI Wealth Advisors's Bioverativ Inc. Common Stock position peaked at $196K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on TCI Wealth Advisors's 13F filing for Q1 2018, filed 30 Apr 2018.